These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 198969)

  • 61. Antiviral action of mouse interferon in heterologous cells.
    Buckler CE; Baron S
    J Bacteriol; 1966 Jan; 91(1):231-5. PubMed ID: 4285534
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cholera toxin inhibits antiviral and growth inhibitory activities of human interferon.
    Degré M
    Proc Soc Exp Biol Med; 1978 Feb; 157(2):253-5. PubMed ID: 202975
    [No Abstract]   [Full Text] [Related]  

  • 63. Interferon-like inhibitor and lysosomal enzyme induced in mice injected with endotoxin.
    Sauter C; Gifford GE
    Nature; 1966 Nov; 212(5062):626. PubMed ID: 4291339
    [No Abstract]   [Full Text] [Related]  

  • 64. On the inhibition of interferon action by inhibitors of fatty acid cyclooxygenase.
    Sarkar FH; Gupta SL
    Virology; 1982 Dec; 123(2):448-51. PubMed ID: 6184880
    [No Abstract]   [Full Text] [Related]  

  • 65. [Functional activity of the lymphoid-macrophage elements of the peritoneal exudate of mice immunized with different myxoviruses, following administration of homologous and heterologous antigens].
    Solilova-Bozhenko LV; Il'in GI; Reikh LI; Luzianina TI
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Aug; (8):76-80. PubMed ID: 4450879
    [No Abstract]   [Full Text] [Related]  

  • 66. Enhancement of phagocytosis by interferon-containing preparations.
    Huang KY; Donahoe RM; Gordon FB; Dressler HR
    Infect Immun; 1971 Nov; 4(5):581-8. PubMed ID: 4343410
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparative study of the efficacy of different forms of interferon therapy in the treatment of mice challenged intranassaly with vesicular stomatitis virus (VSV).
    De Clercq E; De Somer P
    Proc Soc Exp Biol Med; 1971 Oct; 138(1):301-7. PubMed ID: 4331092
    [No Abstract]   [Full Text] [Related]  

  • 68. Effects of butyrate on induction and action of interferon.
    Adolf GR; Swetly P
    Biochem Biophys Res Commun; 1981 Dec; 103(3):806-12. PubMed ID: 6174120
    [No Abstract]   [Full Text] [Related]  

  • 69. Purification of interferon produced in a culture of human granulocytes.
    Hobb DS; Moschera JA; Levy WP; Pestka S
    Methods Enzymol; 1981; 78(Pt A):472-81. PubMed ID: 6173631
    [No Abstract]   [Full Text] [Related]  

  • 70. [A cytologic study of mouse abdominal cavity exudate during in vitro interferon production].
    Khesin IaE; Voronina FV; Amchenkova AM
    Vopr Virusol; 1970; 15(5):544-9. PubMed ID: 5507878
    [No Abstract]   [Full Text] [Related]  

  • 71. [Virological, cytological and karyological characteristics of clones, isolated from L cell cultures chronically infected with vesicular stomatitis virus].
    Amchenkova AM; Sovetova GP
    Vopr Virusol; 1974; (1):8-13. PubMed ID: 4374815
    [No Abstract]   [Full Text] [Related]  

  • 72. Biological properties of mouse interferon bound to a high molecular weight carrier: Blue Dextran 2000.
    Inglot AD; Kisielow B; Inglot O
    Arch Virol; 1979; 60(1):43-50. PubMed ID: 226032
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Tissue antagonist of interferon : murine substance similar to plant lectins].
    Chany-Fournier F; Pauloin A; Chany C
    C R Acad Hebd Seances Acad Sci D; 1977 Oct; 285(8):941-4. PubMed ID: 199376
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Antiproliferative action of swine leukocyte interferon and of an inhibitor of interferon action].
    Parfenov VV; Amchenkova AM; Narovlianskiĭ AN; Tkach TA
    Vopr Virusol; 1987; 32(5):574-6. PubMed ID: 3433715
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Sensitivity of human ovarian carcinoma cells to interferon and other antitumor agents as assessed by an in vitro semi-solid agar technique.
    Epstein LB; Shen JT; Abele JS; Reese CC
    Ann N Y Acad Sci; 1980; 350():228-44. PubMed ID: 6165278
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Dextran T fractions substituted with cibacron blue F3G-A as carriers for mouse interferon.
    Inglot AD; Konieczny M; Charytonowicz D; Chudzio T; Kisielow B; Inglot O; Oleszak E
    Arch Immunol Ther Exp (Warsz); 1980; 28(2):313-22. PubMed ID: 6160828
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [On the origin of fibroblasts in cultures (diffusion chambers) of rat peritoneal fluid cells].
    Mohr W; Carl H; Beneke G
    Res Exp Med (Berl); 1972; 158(4):251-67. PubMed ID: 5085434
    [No Abstract]   [Full Text] [Related]  

  • 78. Mouse interferon in ascitic fluids.
    Buckley SM; Casals J
    Appl Microbiol; 1974 Aug; 28(2):319. PubMed ID: 4853277
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Natural interferon-producing cells in mice.
    Ito Y; Aoki H; Kimura Y; Takano M; Shimokata K; Maeno K
    Infect Immun; 1981 Feb; 31(2):519-23. PubMed ID: 6163718
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Study of the lymphocyte-macrophage reactions after the administration of different myxoviruses into the abdominal cavity].
    Solilova LV; Il'in GI; Reĭkh LIa; Luzianina TIa
    Vopr Virusol; 1973; 18(6):682-6. PubMed ID: 4789976
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.